FIRSTHEALTH MONTGOMERY MEMORIAL CAH
1. Target Overview & Investment Thesis
FIRSTHEALTH MONTGOMERY MEMORIAL CAH is a 3-bed suburban community hospital in MONTGOMERY, NC with $18.2M in net patient revenue and a 7.7% operating margin. The hospital serves a payer mix of 38.1% Medicare, 1.7% Medicaid, and 60.2% commercial.
Thesis: Turnaround. Our ML models identify $1.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.7% to 15.1% (+736bps).
| Net Revenue HCRIS | $18.2M |
| Current EBITDA COMPUTED | $1.4M |
| Operating Margin COMPUTED | 7.7% |
| Occupancy HCRIS | 239.2% |
| Revenue / Bed COMPUTED | $6.1M |
| Net-to-Gross HCRIS | 23.9% |
| Distress Probability ML | 10.3% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of 7.7% places it above the state median. Among 0 size-comparable peers (2-6 beds), the median margin is 0.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (2-6), prioritizing same-state peers. 0 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| FIRSTHEALTH MONTGOMERY MEMORIA (Target) | NC | 3 | $18.2M | 7.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $382K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $364K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $360K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $221K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $12K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $1.4M |
| + RCM Uplift | +$1.3M |
| Pro Forma EBITDA | $2.7M |
| Current Margin | 7.7% |
| Pro Forma Margin | 15.1% |
| WC Released (1x) | $698K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $2.2M | $22.7M | 10.48x | 60.0% |
| Base (11x exit) | 10.0x | 11.0x | $2.2M | $25.6M | 11.86x | 64.0% |
| Bull Case | 9.0x | 11.0x | $1.9M | $30.8M | 15.81x | 73.7% |
| Bull (12x exit) | 9.0x | 12.0x | $1.9M | $34.1M | 17.54x | 77.3% |
| Bear Case | 11.0x | 10.0x | $2.4M | $15.3M | 6.42x | 45.0% |
| Bear (11x exit) | 11.0x | 11.0x | $2.4M | $17.6M | 7.39x | 49.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 0 hospitals with 2-6 beds
- Same-state prioritization (n=2)
- Comp margins: P25=nan% / P50=0.0% / P75=nan%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.